Polycythemia vera secondary prevention
|
Polycythemia vera Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Polycythemia vera secondary prevention On the Web |
|
American Roentgen Ray Society Images of Polycythemia vera secondary prevention |
|
Risk calculators and risk factors for Polycythemia vera secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2] Shyam Patel [3] Synonyms and keywords: Polycythemia rubra vera (PRV); Erythremia; Primary polycythemia; Osler-Vaquez disease; splenomegalic polycythemia
Overview
Secondary prevention strategy following polycythemia vera include low dose aspirin.
Secondary Prevention
Secondary prevention strategy following polycythemia vera include low-dose aspirin 81mg daily to decrease the risk of the following complications:[1]
- Cardiovascular death
- Non-fatal myocardial infarction
- Non-fatal stroke
References
- ↑ Maeda T, Wakasawa T, Shima Y, Tsuboi I, Aizawa S, Tamai I (2006). "Role of polyamines derived from arginine in differentiation and proliferation of human blood cells". Biol Pharm Bull. 29 (2): 234–9. PMID 16462024.